in contrast to a control group consisting of 16 test persons with healthy liver ( 14co2 exhalation 1019 +/- 175 dpm/mmol-co2/70 kg body weight ) the hepatic elimination of the [ 14c ] -aminophenazone in chronic liver diseases ( 626 +/- 203 dpm/mmol co2/70 kg body weight ) was significantly restricted ( p less than 0.001 ) .
C0023884
liver
C0341439
chronic liver